News
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

88,329 Results

Type

Article (2521)
Company Profile (6)
Press Release (85802)

Section

Business (38947)
Career Advice (69)
Deals (5667)
Drug Delivery (6)
Drug Development (11033)
Employer Resources (9)
FDA (1954)
Job Trends (2310)
News (55026)
Policy (3204)

Tag

Date

Today (9)
Last 7 days (77)
Last 30 days (242)
Last 365 days (6700)
2024 (3684)
2023 (6793)
2022 (10112)
2021 (10884)
2020 (9607)
2019 (6350)
2018 (4801)
2017 (4618)
2016 (3885)
2015 (4797)
2014 (3302)
2013 (1984)
2012 (2216)
2011 (2316)
2010 (2362)

Filters

Type

Article (2521)
Company Profile (6)
Press Release (85802)

Section

Business (38947)
Career Advice (69)
Deals (5667)
Drug Delivery (6)
Drug Development (11033)
Employer Resources (9)
FDA (1954)
Job Trends (2310)
News (55026)
Policy (3204)

Tag

Date

Today (9)
Last 7 days (77)
Last 30 days (242)
Last 365 days (6700)
2024 (3684)
2023 (6793)
2022 (10112)
2021 (10884)
2020 (9607)
2019 (6350)
2018 (4801)
2017 (4618)
2016 (3885)
2015 (4797)
2014 (3302)
2013 (1984)
2012 (2216)
2011 (2316)
2010 (2362)

88,329 Results for "34".

Sort By

Pharm Country

Tiziana Receives $3.4 Million in Non-Dilutive Funding

Tiziana Life Sciences, Ltd., a biotechnology company developing breakthrough therapies in neurodegenerative disease secondary to active neuroinflammatory processes announced that it had received non-dilutive funding of $3.4 million and issued a corporate update video available here.

June 28, 2024
·
2 min read
Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program

Tonix Pharmaceuticals Holding Corp. announced it has been awarded an Other Transaction Agreement with a potential for up to $34 million over five years by the Defense Threat Reduction Agency, an agency within the U.S. Department of Defense.

July 1, 2024
·
7 min read
U.S. Cancer Biopsy Market Size to Surpass USD 29.34 Bn by 2033

According to latest study, the U.S. cancer biopsy market size was valued at USD 10.21 billion in 2023 and is projected to surpass around USD 29.34 billion by 2033, registering a CAGR of 11.13% over the forecast period of 2024 to 2033.

May 16, 2024
·
1 min read
Genetown

Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Allurion Technologies, Inc. today announced that it will be participating in the 34th Annual Oppenheimer Healthcare MedTech & Services Conference, taking place on March 12 - 13, 2024.

March 13, 2024
·
1 min read
BioCapital

Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference

Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference.

March 6, 2024
·
1 min read
U.S. Nuclear Medicine Market Size to Hit USD 19.34 Bn by 2033

According to recent study by Nova one advisor, the U.S. nuclear medicine market size was estimated at USD 5.85 billion in 2023 and is projected to hit around USD 19.34 billion by 2033, growing at a CAGR of 12.7% during the forecast period from 2024 to 2033.

May 16, 2024
·
1 min read
Policy

Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery

Sight Sciences, Inc. today announced that it received a positive jury trial verdict of $34 million associated with the patent infringement case it filed on September 16, 2021 against Alcon Inc., Alcon Vision, LLC, Alcon Research, LLC, and Ivantis, Inc.

April 29, 2024
·
6 min read
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming Oppenheimer 34th Annual Healthcare MedTech & Services Conference.

March 6, 2024
·
1 min read
Biotech Beach

RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference

RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming 34th Annual Oppenheimer Healthcare Conference.

February 29, 2024
·
1 min read
Genetown

Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference

Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference.

January 31, 2024
·
1 min read

1 of 8,833

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
Hotbeds
About
More

© 1985 - 2024 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin